Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Study Phase : Discovery Platform
Sponsor : Zogenix
Deal Size : $115.0 million
Deal Type : Collaboration
Details : Under the collaboration, Tevard will utilize its two unique tRNA-based discovery platforms focused on mRNA Stabilization and Nonsense Codon Suppression to discover and advance novel drug candidates for the treatment of Dravet syndrome and other genetic e...
Product Name : Undisclosed
Product Type : Cell and Gene therapy
Upfront Cash : $10.0 million
March 12, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Highest Development Status : Discovery Platform
Sponsor : Zogenix
Deal Size : $115.0 million
Deal Type : Collaboration